ADD ANYTHING HERE OR JUST REMOVE IT…
Wrong menu selected
Acarix Acarix
  • Product

    Background

    • What is Coronary Artery Disease (CAD)?
    • Diagnosing CAD

    About the product

    • The CADScor® System
    • How does it work
  • Resources

    Testimonials

    • HCP stories
    • Patient stories

    References

    • Clinical Studies
    • Questionnaire
    • Downloads (US)
    • Downloads (EU)
    • Education

    Support

    • Training
    • FAQ
    • Reimbursement

    Physician Locator

    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Rights Issue/Warrant Program
    • Previous Rights Issue
    • Investor Presentations
  • Company

    Who we are

    • About Acarix
    • leadership
    • Join the team

    Get in touch

    • Contact us
    • Investigator Initiated Study
  • News
    • Press
    • Events
    • Social Media
Account
Search
Book a Demo
Acarix Acarix
Book a demo
Menu
author-avatar acarix
Press
August 6, 2024
06 Aug 2019

Acarix AB (publ) publicerar delårsrapport, januari – juni 2019

Acarix AB (publ) publicerar delårsrapport, januari – juni 2019 Malmö den 6 augusti 2019 CADScor®System inkluderad i Storbritanniens...
Continue reading
author-avatar acarix
Press
August 6, 2024
06 Aug 2019

Acarix AB (publ) publishes Interim Report, January – June 2019

Acarix AB (publ) publishes Interim Report, January – June 2019 Malmö, August 6, 2019 CADScor®System Included in UK guidance forruli...
Continue reading
author-avatar acarix
Press
August 6, 2024
05 Aug 2019

CADScor®System – Betydligt effektivare än nuvarande metoder

Press release Malmö Augusti 5, 2019 CADScor®System – Betydligt effektivare än nuvarande metoder Acarix AB (publ) (ACARIX: FN Stockho...
Continue reading
author-avatar acarix
Press
August 6, 2024
05 Aug 2019

CADScor®System – Significantly more effective than current practice

Press release Malmö August 5, 2019 CADScor®System – Significantly more effective than current practice Acarix AB (publ) (ACARIX: F...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Jul 2019

Kallelse till extra bolagsstämma i Acarix AB

Pressrelease 17 juli 2019 Kallelse till extra bolagsstämma i Acarix AB Aktieägarna i Acarix AB, org.nr 559009-0667, ("Bolage...
Continue reading
author-avatar acarix
Press
August 6, 2024
17 Jul 2019

Notice of extra general meeting in Acarix AB

Press release July 17, 2019 Notice of extra general meeting in Acarix AB The shareholders of Acarix AB, reg. no. 559009-0667, (the ...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Jun 2019

Acarix CADScor®System – nu inkluderad i NICEs riktlinjer för vård och hälsa

Press release Malmö Juni 27, 2019 Acarix CADScor®System – nu inkluderad i NICEs riktlinjer för vård och hälsa Acarix AB (publ) (AC...
Continue reading
author-avatar acarix
Press
August 6, 2024
27 Jun 2019

Acarix CADScor®System included in NICE guidelines (UK)

Press release Malmö June 27, 2019 Acarix CADScor®System included in NICE guidelines (UK) Acarix AB (publ) (ACARIX: FN Stockholm) tod...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Jun 2019

Acarix participates on the Redeye Growth Day, Monday 10 June 2019

Acarix participates on the Redeye Growth Day, Monday 10 June 2019 On Monday, June the 10th at 3.40 PM, Per Persson CEO for Acarix,...
Continue reading
author-avatar acarix
Press
August 6, 2024
07 Jun 2019

Acarix presenterar på Redeye Growth Day, 10 juni 2019

Acarix presenterar på Redeye Growth Day, 10 juni 2019 Den 10 juni kl. 15.40 presenterar Per Persson, VD för Acarix, den senast...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 May 2019

Kommuniké från årsstämman i Acarix

Press release Malmö, Maj 20, 2019 Kommuniké från årsstämman i Acarix Årsstämman 2018 i Acarix AB ("Acarix" elle...
Continue reading
author-avatar acarix
Press
August 6, 2024
20 May 2019

Announcement from Acarix’s annual general meeting

Press release  Malmö, May 20, 2019 Announcement from Acarix's annual general meeting The annual general meeting ("AGM�...
Continue reading
  • «
  • ‹
  • 28
  • 29
  • 30
  • 31
  • 32
  • ›
  • »
Acarix AB
Jungmansgatan 12
211 19 Malmö
SE
[email protected]

Product

Background

  • What is Coronary Artery Disease (CAD)?
  • Diagnosing CAD

About the product

  • The CADScor® System
  • How does it work

Resources

Testimonials

  • HCP stories
  • Patient stories

Support

  • Training
  • FAQ

References

  • Clinical Studies
  • Downloads (US)
  • Downloads (EU)

Investors

  • Corporate Governance
  • General Meetings
  • Financial Reports and Calendar
  • The Acarix Share
  • Rights Issue
  • Investor Presentations

Company

Who we are

  • About Acarix
  • Management
  • Join the team

Get in touch

  • Contact us
  • LinkedIn
  • Twitter

News

  • Press
  • Events
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy
  • Cookie policy
  • Privacy Policy: Clinical Studies
  • Privacy Policy

Acarix, 2025. All rights reserved V5

  • Products
    • Background
    • What is Coronary Artery Disease
    • Diagnosing CAD
    • About the product
    • The Cadscor System
    • How Does it Work
  • Resources
    • Testimonial
    • HCP Stories
    • Patients Stories
    • References
    • Clinical Studies
    • Downloads (US)
    • Downloads (EU)
    • Support
    • Training
    • Faq
    • Reimbursement
    • Physician Locator
    • Germany
  • Investors
    • Corporate Governance
    • General Meetings
    • Financial Reports and Calendar
    • The Acarix Share
    • Right Issue
    • Previous Rights Issue
    • Investor Presentations
  • Company
    • Who we are
    • About Acarix
    • Leadership
    • Join The Team
    • Get in touch
    • Contact Us
    • Investigator Initiated Study
  • News
    • News
    • Press
    • Events
    • Socialmedia
Start typing to see products you are looking for.